Impakter
  • PARTNERS
  • ABOUT US
    • Our Story
    • Team
    • Write for Impakter
    • Contact Us
    • Privacy Policy
No Result
View All Result
  • Climate
  • Business
  • Energy
  • Tech
  • Politics
  • Health
  • Food & Agriculture
  • Society
  • Climate
  • Business
  • Energy
  • Tech
  • Politics
  • Health
  • Food & Agriculture
  • Society
No Result
View All Result
Impakter
No Result
View All Result

Glaucoma is quiet, so your plan has to be loud

byHannah Fischer-Lauder
April 22, 2026
in Health
A woman receiving a consultancy on her glaucoma.

A woman receiving a consultancy by a doctor on her glaucoma. -- Photo Credit: freepil

Robert D. Butcher, O.D., says that a search for an eye doctor in Kansas City often comes up when someone hears “glaucoma suspect” and realizes that waiting for symptoms is not a strategy. Glaucoma is a long game, and long games need structure, not panic.

Discover Vision Centers lists glaucoma among the medical eye conditions it treats. That matters because glaucoma care is not a one-time visit. Glaucoma care is monitoring, treatment, and follow-through.

The “silent thief” problem (and what actually prevents it)

Glaucoma can progress without pain. Glaucoma can change peripheral vision first, which is why early disease can feel invisible to the patient. A quiet disease deserves a loud plan.

Baseline testing turns worry into data

Baseline tests create a starting point. Baseline tests make future change measurable. Baseline tests turn uncertainty into trend tracking. Baselines turn fear into data, and data protects decisions.

Macular OCT and visual fields tell a clearer story together

OCT shows structure. Visual fields show function. An article describes macular OCT as “nearly indispensable” in glaucoma clinical practice and notes its usefulness for examining retinal ganglion cells and axons affected by glaucoma. [1]

A peer-reviewed review also explains that OCT aids detection and monitoring of glaucomatous structural damage and emphasizes that early detection and monitoring are critical because glaucoma can cause irreversible blindness. [2]

Structure shows what is changing, and function shows what it is costing.

Treatments that match the stage, not the panic

Glaucoma treatment lowers intraocular pressure to reduce the risk of optic nerve damage. Treatments can include drops, laser procedures, or surgery, depending on the stage and patient factors.

Follow-up is treatment (and why it’s easy to miss)

Follow-up is hard because glaucoma can feel like “nothing is happening.” Dove Press reviews on adherence highlight that improving persistence can involve reminders, installation aids, and communication strategies that make the plan doable. [3]

Follow-up is treatment because monitoring is how glaucoma care works.

Medication routines that real people can keep

Medication routines work when the routine matches real life. A plan works better when the “why” is clear, the schedule is realistic, and the patient has tools that support consistency.

The best medication plan is the one you can actually follow.

The next step that protects independence

Independence depends on consistency. The procedure attributes framework makes that practical by keeping recovery, postoperative care, risks, and technology inside the same plan rather than scattered across multiple conversations.

References: 

[1] Lynda Charters “Macular OCT: A must for treating glaucoma patients.” Jan 8, 2020;

[2] Alexi Geevarghese, Gadi Wollstein, Hiroshi Ishikawa, Joel S Schuman: “Optical Coherence Tomography and Glaucoma”, Peer-reviewed review (NIH/PMC) on OCT and glaucoma detection/monitoring, Jul 9, 2021;

[3] Tapply I, Broadway DC: “Improving Adherence to Topical Medication in Patients with Glaucoma”, a review on improving adherence to topical glaucoma medication, Jul 2, 2021;


Editor’s Note: The opinions expressed here by the authors are their own, not those of impakter.com — In the Cover Photo: Glaucoma is a grout of asymptomatic eye diseases. They damage the optic nerve, often due to elevated intraocular pressure.  Cover Photo Credit: 

Share
WhatsApp LinkedIn X Facebook
Tags: GlaucomaMacular OCTMedication routines
Previous Post

China and India Lead the Green Hydrogen Expansion

Next Post

The Iran War Is Breaking the Global Gas Supplies

Hannah Fischer-Lauder

Hannah Fischer-Lauder

Hannah Fischer-Lauder is an anthropologist and a graduate of McGill University. After 15 years of field research in Madagascar and New Guinea, she has returned to Europe and America to study cultural diversity in western society.

Next Post
ESG news on Gas Supplies, Ukraine restarting an old gas pipeline, Australia betting on biofuels, and Indonesia betting on waste-to-energy solutions.

The Iran War Is Breaking the Global Gas Supplies

Related News

Timur Turlov

FIDE Election 2026: Timur Turlov Puts Digital Growth and Education at the Center of His Campaign

September 22, 2026
Stunning sunset view of cargo ships and cranes at the Port of Hamburg, epitomizing global trade and logistics.

Marine Biodiesel Hits Record Low, Undercuts Fossil Fuels

September 22, 2026

Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com

Registered Office Address

Klimado GmbH
Niddastrasse 63,

60329, Frankfurt am Main, Germany


IMPAKTER is a Klimado GmbH website

Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).


Office Hours - Monday to Friday

9.30am - 5.00pm CEST


Email

stories [at] impakter.com

By Audience

  • TECH
    • Start-up
    • AI & MACHINE LEARNING
    • Green Tech
  • ENVIRONMENT
    • Biodiversity
    • Energy
    • Circular Economy
    • Climate Change
  • INDUSTRY NEWS
    • Entertainment
    • Food and Agriculture
    • Health
    • Politics & Foreign Affairs
    • Philanthropy
    • Science
    • Sport
    • Editorial Series

ESG/Finance Daily

  • ESG News
  • Business

About Us

  • Team
  • Partners
  • Write for Impakter
  • Contact Us
  • Privacy Policy

© 2026 IMPAKTER. All rights reserved.

No Result
View All Result
  • Climate
  • Business
  • Energy
  • Tech
  • Politics
  • Health
  • Food & Agriculture
  • Society

© 2026 IMPAKTER. All rights reserved.